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Using an optimized and validated GC×GC-HRTOFMS method we developed for the metabolic
profiling of human serum, in combination with a strict QA/QC system, we were able to highlight
sets of biomarkers capable to discriminate between various inflammation phenotypes (high,
low, remission, and control) representatives of inflammatory bowel diseases. During this proof-
of-concept study, two main challenges of untargeted metabolomics were especially considered.
First, the issue of data handling –large datasets and low number of samples compared to
variables- was solved by the definition of a workflow of data preprocessing and processing,
including the creation of a study template, the rigorous selection of good chromatographic quality
features, and the multiplication of statistic techniques to be combined before test validation. In
practice, 94 injections were made over 4 weeks, consisting of 70 study samples along with 16
QC samples and 8 reinjections due to QC system rejection. The all-chromatograms template
included 524 verified features that were then reduced to less than two hundred after selection
of the ones having an analytical variation under 30%, based on the QC samples. This resulted
in the finding of robust biomarkers that positively discriminated between the different phenotypes
of inflammation, including high and low inflammation, remission, and healthy statutes.
Second, the identification of unknown compounds was enhanced by using state-of-the-art high-
resolution (HR) time-of-flight mass spectrometry and allowed to name and characterize putative
biomarkers with higher degree of confidence.
In conclusion, this study showed the usefulness of optimized and fully controlled GC×GC-
HRTOFMS in clinical research for proper biomarker identification. The collection of such data
will also possibly contribute to biological pathways interpretation.
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